These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
325 related articles for article (PubMed ID: 30770577)
1. An in vitro biofilm model of Staphylococcus aureus infection of bone. Sweeney E; Lovering AM; Bowker KE; MacGowan AP; Nelson SM Lett Appl Microbiol; 2019 Apr; 68(4):294-302. PubMed ID: 30770577 [TBL] [Abstract][Full Text] [Related]
2. Rifampicin-containing combinations are superior to combinations of vancomycin, linezolid and daptomycin against Staphylococcus aureus biofilm infection in vivo and in vitro. Jørgensen NP; Skovdal SM; Meyer RL; Dagnæs-Hansen F; Fuursted K; Petersen E Pathog Dis; 2016 Jun; 74(4):ftw019. PubMed ID: 27036412 [TBL] [Abstract][Full Text] [Related]
3. Effects of antibiotics on biofilm and unattached cells of a clinical Staphylococcus aureus isolate from bone and joint infection. Marquès C; Tasse J; Pracros A; Collin V; Franceschi C; Laurent F; Chatellier S; Forestier C J Med Microbiol; 2015 Sep; 64(9):1021-1026. PubMed ID: 26297246 [TBL] [Abstract][Full Text] [Related]
4. A simple infection model using pre-colonized implants to reproduce rat chronic Staphylococcus aureus osteomyelitis and study antibiotic treatment. Monzón M; García-Alvarez F; Laclériga A; Gracia E; Leiva J; Oteiza C; Amorena B J Orthop Res; 2001 Sep; 19(5):820-6. PubMed ID: 11562127 [TBL] [Abstract][Full Text] [Related]
5. Activity of bone cement loaded with daptomycin alone or in combination with gentamicin or PEG600 against Staphylococcus epidermidis biofilms. Peñalba Arias P; Furustrand Tafin U; Bétrisey B; Vogt S; Trampuz A; Borens O Injury; 2015 Feb; 46(2):249-53. PubMed ID: 25498330 [TBL] [Abstract][Full Text] [Related]
7. A combined pharmacodynamic quantitative and qualitative model reveals the potent activity of daptomycin and delafloxacin against Staphylococcus aureus biofilms. Bauer J; Siala W; Tulkens PM; Van Bambeke F Antimicrob Agents Chemother; 2013 Jun; 57(6):2726-37. PubMed ID: 23571532 [TBL] [Abstract][Full Text] [Related]
8. Emergence of a clinical daptomycin-resistant Staphylococcus aureus isolate during treatment of methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis. Marty FM; Yeh WW; Wennersten CB; Venkataraman L; Albano E; Alyea EP; Gold HS; Baden LR; Pillai SK J Clin Microbiol; 2006 Feb; 44(2):595-7. PubMed ID: 16455920 [TBL] [Abstract][Full Text] [Related]
11. Impact of sarA on daptomycin susceptibility of Staphylococcus aureus biofilms in vivo. Weiss EC; Zielinska A; Beenken KE; Spencer HJ; Daily SJ; Smeltzer MS Antimicrob Agents Chemother; 2009 Oct; 53(10):4096-102. PubMed ID: 19651914 [TBL] [Abstract][Full Text] [Related]
12. A review of telavancin activity in in vitro biofilms and animal models of biofilm-associated infections. Chan C; Hardin TC; Smart JI Future Microbiol; 2015; 10(8):1325-38. PubMed ID: 26083676 [TBL] [Abstract][Full Text] [Related]
13. Antibiofilm Activity and Synergistic Inhibition of Staphylococcus aureus Biofilms by Bactericidal Protein P128 in Combination with Antibiotics. Nair S; Desai S; Poonacha N; Vipra A; Sharma U Antimicrob Agents Chemother; 2016 Dec; 60(12):7280-7289. PubMed ID: 27671070 [TBL] [Abstract][Full Text] [Related]
14. Application of a rat osteomyelitis model to compare in vivo and in vitro the antibiotic efficacy against bacteria with high capacity to form biofilms. Gracia E; Laclériga A; Monzón M; Leiva J; Oteiza C; Amorena B J Surg Res; 1998 Oct; 79(2):146-53. PubMed ID: 9758730 [TBL] [Abstract][Full Text] [Related]
15. The anti-biofilm effect of macrolides in a rat model of S. aureus foreign-body infection: Might it be of clinical relevance? El Haj C; Murillo O; Ribera A; Garcia-Somoza D; Tubau F; Cabellos C; Cabo J; Ariza J Med Microbiol Immunol; 2017 Feb; 206(1):31-39. PubMed ID: 27639707 [TBL] [Abstract][Full Text] [Related]
16. Staphylococcus aureus develops increased resistance to antibiotics by forming dynamic small colony variants during chronic osteomyelitis. Tuchscherr L; Kreis CA; Hoerr V; Flint L; Hachmeister M; Geraci J; Bremer-Streck S; Kiehntopf M; Medina E; Kribus M; Raschke M; Pletz M; Peters G; Löffler B J Antimicrob Chemother; 2016 Feb; 71(2):438-48. PubMed ID: 26589581 [TBL] [Abstract][Full Text] [Related]
17. Use of xylitol to enhance the therapeutic efficacy of polymethylmethacrylate-based antibiotic therapy in treatment of chronic osteomyelitis. Beenken KE; Bradney L; Bellamy W; Skinner RA; McLaren SG; Gruenwald MJ; Spencer HJ; Smith JK; Haggard WO; Smeltzer MS Antimicrob Agents Chemother; 2012 Nov; 56(11):5839-44. PubMed ID: 22948866 [TBL] [Abstract][Full Text] [Related]
18. Clinical progression of methicillin-resistant Staphylococcus aureus vertebral osteomyelitis associated with reduced susceptibility to daptomycin. Vikram HR; Havill NL; Koeth LM; Boyce JM J Clin Microbiol; 2005 Oct; 43(10):5384-7. PubMed ID: 16208025 [TBL] [Abstract][Full Text] [Related]
19. Therapy with gentamicin-PMMA beads, gentamicin-collagen sponge, and cefazolin for experimental osteomyelitis due to Staphylococcus aureus in rats. Mendel V; Simanowski HJ; Scholz HC; Heymann H Arch Orthop Trauma Surg; 2005 Jul; 125(6):363-8. PubMed ID: 15864679 [TBL] [Abstract][Full Text] [Related]
20. Deferiprone and Gallium-Protoporphyrin Have the Capacity to Potentiate the Activity of Antibiotics in Richter K; Thomas N; Zhang G; Prestidge CA; Coenye T; Wormald PJ; Vreugde S Front Cell Infect Microbiol; 2017; 7():280. PubMed ID: 28690982 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]